A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B
Status:
Active, not recruiting
Trial end date:
2023-09-30
Target enrollment:
Participant gender:
Summary
Current clinical practices has shown promising prospects of the therapy strategy of
interferon combined with nucleos(t)ides in patients with chronic hepatitis B, but the safety
and efficacy has not been fully studied. This study is aimed to exploit the safety and
efficacy of the study drug, Peginterferon alfa-2b injection, with nucleos(t)ide (NAs),
tenofovir disoproxil fumarate tablets (TDF), in the patients with hepatitis B, who has
previously treated with nucleos(t)ides and who are treatment naïve.